Last reviewed · How we verify
Placebo for terbutaline sulphate
Placebo for terbutaline sulphate is a Small molecule drug developed by AstraZeneca. It is currently in Phase 3 development for Treatment of asthma symptoms. Also known as: Placebo powder for inhalation.
Placebo does not have a pharmacological effect.
Placebo does not have a pharmacological effect. Used for Treatment of asthma symptoms.
At a glance
| Generic name | Placebo for terbutaline sulphate |
|---|---|
| Also known as | Placebo powder for inhalation |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease.
Approved indications
- Treatment of asthma symptoms
Common side effects
- No adverse events
Key clinical trials
- Acute Tocolysis With Terbutaline for Suspected Fetal Distress (NA)
- A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma (PHASE3)
- A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma. (PHASE3)
- Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain (PHASE2)
- Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3 (PHASE3)
- Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement (PHASE4)
- Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for terbutaline sulphate CI brief — competitive landscape report
- Placebo for terbutaline sulphate updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Placebo for terbutaline sulphate
What is Placebo for terbutaline sulphate?
How does Placebo for terbutaline sulphate work?
What is Placebo for terbutaline sulphate used for?
Who makes Placebo for terbutaline sulphate?
Is Placebo for terbutaline sulphate also known as anything else?
What development phase is Placebo for terbutaline sulphate in?
What are the side effects of Placebo for terbutaline sulphate?
Related
- Manufacturer: AstraZeneca — full pipeline
- Indication: Drugs for Treatment of asthma symptoms
- Also known as: Placebo powder for inhalation
- Compare: Placebo for terbutaline sulphate vs similar drugs
- Pricing: Placebo for terbutaline sulphate cost, discount & access